Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6–8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study
Author:
Matur Ramesh V.,
Thuluva SubhashORCID,
Gunneri Subbareddy,
Yerroju Vijay,
reddy Mogulla Rammohan,
Thammireddy KamalORCID,
Paliwal Piyush,
Mahantshetty Niranjana S.,
Ravi Mandyam Dhati,
Prashanth S.,
Verma Savita,
Narayan Jai Prakash